HT
MBOT icon

Headlands Technologies’s Microbot Medical MBOT Stock Holding History

Headlands Technologies’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-169
Closed -$172 – 1399
2024
Q2 		$172 Buy
+169
New +$174 ﹤0.01% 1080

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $100M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Headlands Technologies's MBOT Position: Q3 2024 in Review

Headlands Technologies sold out of Microbot Medical (MBOT) in Q3 2024, closing a stake of 169 shares — an estimated $172 sold.

Headlands Technologies first reported a position in MBOT in Q2 2024 and held it in 1 quarter. The position peaked at $172 in Q2 2024. 25 funds tracked by Wall St. Rank hold MBOT as of Q3 2024.

  • Headlands Technologies reported no remaining Microbot Medical position as of Q3 2024 after selling out during the quarter.
  • Headlands Technologies sold 169 Microbot Medical shares in Q3 2024, an estimated $172.
  • Headlands Technologies first reported a position in Microbot Medical in Q2 2024 and held it in 1 quarter.
  • Headlands Technologies's Microbot Medical position peaked at $172 in Q2 2024.
  • 25 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2024.

Based on Headlands Technologies's 13F filing for Q3 2024, filed 12 Nov 2024.